Global Health Board of Directors

Get the latest insights into the leadership at Global Health. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Dr. Naresh Trehan Chairman & Managing Director
Mr. Sunil Sachdeva Non Executive Director
Mr. Pankaj Sahni Director & Group CFO
Dr. Ravi Gupta Independent Director
Mr. Rajan Bharti Mittal Independent Director
Mr. Ravi Kant Jaipuria Non Exe. & Nominee Director
Mr. Hari Shanker Bhartia Independent Director
Ms. Praveen Mahajan Independent Director
Mr. Vikram Singh Mehta Independent Director

Global Health Share price

MEDANTA

1420.8

6.40 (-0.45%)
NSE
BSE
Last updated on 4 Sep, 2025 | 15:57 IST
BUYSELL
Today's High

1449.80

Today's Low

1414.90

52 Week Low

935.50

52 Week High

1456.50

The current prices are delayed, login to your account for live prices

Global Health FAQs

The board at Global Health consists of experienced professionals, including Dr. Naresh Trehan , Mr. Sunil Sachdeva , and others, overseeing the company’s strategic and corporate governance.

Directors at Global Health are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Dr. Naresh Trehan is the current chairman at Global Health.

Executive directors at Global Health are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Global Health adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Global Health, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.